Navigation Links
Aspirin May Reduce Risk of Liver Cancer, Death From Liver Disease
Date:11/28/2012

WEDNESDAY, Nov. 28 (HealthDay News) -- Aspirin use seems to be associated with a decreased risk of liver cancer and death from chronic liver disease, according to a large new study.

This new study included more than 300,000 people aged 50 to 71, who reported their aspirin and nonsteroidal anti-inflammatory drug (NSAID) use and were followed for 10 to 12 years. During that time, more than 400 participants died from chronic liver disease and 250 were diagnosed with liver cancer.

Compared to people who didn't take NSAIDs, people who took aspirin were 45 percent less likely to die from chronic liver disease and 41 percent less likely to be diagnosed with liver cancer. People who took non-aspirin NSAIDs were 26 percent less likely to die from chronic liver disease but no less likely to be diagnosed with liver cancer.

If these findings are confirmed, they could lead to new ways to prevent chronic liver disease and liver cancer, concluded study author Dr. Vikrant Sahasrabuddhe, of the division of cancer epidemiology and genetics at the U.S. National Cancer Institute, and colleagues.

While the study found an association between aspirin use and reduced risk for liver problems, it did not prove cause-and-effect.

The study was published Nov. 28 in the Journal of the National Cancer Institute.

Previous research has linked chronic inflammation due to liver disease to cellular processes that could promote cancer development, while other research has suggested that aspirin and other types of NSAIDs may help reduce the risk of some cancers, a journal news release noted.

Although it is worthwhile to study the potential of new prevention methods such as NSAID use, it also is necessary to focus on improving established prevention practices and interventions, Dr. Isra Levy and Dr. Carolyn Pim, both from the department of epidemiology and community medicine at the University of Ottawa, in Canada, noted in an accompanying journal editorial.

The known causes of chronic liver disease and liver cancer are hepatitis B and C virus infections and alcohol use. A link with obesity and diabetes also has been suggested.

Cheap, readily available interventions, such as vaccines for hepatitis B and C virus, already exist, but "effective strategies for reduction of [hepatitis B] and [hepatitis C] are not always available or fully applied," the editorialists wrote.

They also noted that alcohol abuse and obesity are complex issues that require interventions at the individual and health-system levels.

More information

The American Liver Foundation outlines 25 ways to love your liver.

-- Robert Preidt

SOURCE: Journal of the National Cancer Institute, news release, Nov. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Daily Aspirin May Help Those at Risk for Recurrent Blood Clots
2. Daily Aspirin May Bolster Aging Brain, Study Shows
3. Genes May Determine Aspirins Effect on Advanced Colon Cancer
4. Gene mutation identifies colorectal cancer patients who live longer with aspirin therapy
5. Adding Plavix to Aspirin Doesnt Help Guard Against Second Stroke: Study
6. Aspirin may help men with prostate cancer live longer, study suggests
7. Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer
8. Daily Aspirin May Cut Cancer Deaths, Another Study Finds
9. Daily aspirin usage associated with lower cancer mortality
10. Study adds to evidence daily aspirin linked to lower cancer mortality
11. Aspirin protects against Barretts esophagus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin May Reduce Risk of Liver Cancer, Death From Liver Disease
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: